| (Values in U.S. Thousands) | Dec, 2025 | Sep, 2025 | Jun, 2025 | Mar, 2025 | Dec, 2024 |
| Sales | 4,220,770 | 4,326,760 | 4,138,840 | 3,846,740 | 3,937,590 |
| Sales Growth | -2.45% | +4.54% | +7.59% | -2.31% | -5.68% |
| Net Income | 425,170 | 841,840 | 612,820 | 560,990 | 994,260 |
| Net Income Growth | -49.50% | +37.37% | +9.24% | -43.58% | +76.37% |
Otsuka Holdings CO ADR (OTSKY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Otsuka Holdings Co Ltd is a pharmaceutical company. It manufactures, sells, imports and exports pharmaceutical products, clinical testing and medical equipment for intractable diseases. Otsuka Holdings Co Ltd is based in Tokyo, Japan.
Fiscal Year End Date: 12/31